4S

A dramatic increase in the number of niche drugs with smaller markets may result from the sequencing of the human genome. As the information flow from this project speeds up, a number of pharmaceutical industry watchers are predicting this and other profound changes. Another likely effect is a reduction in basic research costs, but also a concomitant drop in profits from individual drugs.